SWARM Biotactics nabs €13M for biobots

This is one of the clearest bets yet on embodied AI moving off screens and into ugly real-world terrain. The pitch is less about novelty than logistics: cheap, persistent sensing in denied environments where drones and ground robots break down.

• –The company is starting with defense and security, which gives the technology a clear budget owner and an urgent deployment case
• –The funding is earmarked for operational pilots, production of sensor backpacks and neural interfaces, and expansion of R&D and go-to-market teams
• –SWARM’s core claim is that biology can solve access and endurance problems that still limit traditional field robotics
• –The upside is a new class of low-signature reconnaissance and rescue tools; the downside is immediate dual-use and ethics scrutiny around militarized bio-robotics